ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1731

Validation of the 2017 Weighted Criteria in Pediatric Systemic Lupus Erythematosus (SLE)

Meiqian Ma 1, Joyce Hui-Yuen2, Jane Cerise 3, Sabah Iqbal 4 and B. Anne Eberhard 5, 1Cohen Children's Medical Center Northwell Health, Lake Success, NY, 2Cohen Children's Medical Center, Northwell Health, New Hyde Park, NY, 3Feinstein Institute for Medical Research, Manhasset, 4Hofstra Northwell School of Medicine, Hempstead, 5Cohen Children's Medical Center Northwell Health, Lake Success

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: pediatric lupus, validation and classification criteria

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 11, 2019

Title: Pediatric Rheumatology – ePoster II: SLE, Juvenile Dermatomyositis, & Scleroderma

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Different classification criteria for systemic lupus erythematosus (SLE) have been proposed over many years. The most widely used and accepted criteria have been the 1997 ACR criteria. In 2012, the SLICC criteria were published in an attempt to improve clinical relevance of SLE criteria and address concerns with the 1997 ACR criteria. In 2017, a weighted criteria were proposed at the ACR meeting. Our aim was to validate the 2017 weighted criteria for pediatric-onset SLE.

Methods: Retrospective chart review of patients with a clinical diagnosis of SLE diagnosed before the age of 19 years at our tertiary care center between 2003 and 2018. The 2017 weighted, 2012 SLICC, and 1997 ACR classification criteria were applied to these patients, and compared against a gold standard of physician diagnosis. Autoimmune controls were defined as patients who were referred for serologies positive for ANA only but who did not fulfill criteria for diagnosis of SLE at the initial visit, or were diagnosed with another autoimmune disease.

Results: There were 156 patients (82.7% female) who were diagnosed with SLE over the past 15 years. The mean age at diagnosis was 13.1±2.8 years, with 21.8% Asian, 27.6% Black, 26.9% Caucasian, 22.4% Other, and 1.3% Unknown; 23.1% also identified as Hispanic. pSLE patients had a median of 6 of 11 (range 2-9) positive domains and a median of 21 (range 6-41) points by 2017 weighted criteria. The most commonly met domains were antibodies and complement, and the most frequently met clinical criteria were hematologic and synovitis. The sensitivity for the 2017 weighted criteria was 97.4 (CI: 0.94-0.99) and specificity was 98.4 (CI: 0.97-0.99). The median score was 21. The sensitivity for the 2012 SLICC criteria was 97.4 (CI: 0.94-0.99) and specificity was 99.7 (CI: 0.99-1.00). The sensitivity for the 1997 ACR criteria was 87.2 (CI: 0.81-0.92) and specificity was 100 (CI: 0.99-1.00).

Conclusion: The 2017 weighted criteria and the 2012 SLICC were more sensitive, and similarly specific to the 1997 ACR criteria. There were no significant difference in sensitivity and specificity between the 2017 weighted and 2012 SLICC criteria. The sensitivity findings are comparable with the observed sensitivities in the adult population. Analyses are underway to further evaluate the performances of these criteria in a larger cohort of patients.


Disclosure: M. Ma, None; J. Hui-Yuen, None; J. Cerise, None; S. Iqbal, None; B. Eberhard, None.

To cite this abstract in AMA style:

Ma M, Hui-Yuen J, Cerise J, Iqbal S, Eberhard B. Validation of the 2017 Weighted Criteria in Pediatric Systemic Lupus Erythematosus (SLE) [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/validation-of-the-2017-weighted-criteria-in-pediatric-systemic-lupus-erythematosus-sle/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/validation-of-the-2017-weighted-criteria-in-pediatric-systemic-lupus-erythematosus-sle/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology